PATENT CLAIM ANALYSIS

Application Number: 15751163
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "115000"]

Abstract:
The invention relates to capthepsin K inhibitors and uses thereof, specifically relates to a class of compounds having the formula (I) which are used for treating or preventing cathepsin dependent diseases or conditions, specifically, wherein the cathepsin is capthepsin K. The compounds and compositions thereof can be used as bone resorption inhibitors for the treatment of associated diseases.

Claim (Index 10):
The pharmaceutical composition of  claim 9  further comprising an organic bisphosphonic acid compound, an estrogen receptor modulator, an estrogen receptor beta modulator, an androgen receptor modulator, an inhibitor of osteoclast proton ATPase, an inhibitor of HMG-CoA reductase, an integrin receptor antagonist, or an osteoblast anabolic agent, a non-steroidal anti-inflammatory drug, a selective cyclooxygenase-2 inhibitor, an interleukin-1\u03b2 inhibitor, a LOX/COX inhibitor, vitamin D, phytoestrogen, calcitonin, strontium ranelate, odanacatib, ONO5334, MIV-711, MIV-710, and a pharmeceutically acceptable salt and a combination thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.42222
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12734224', '14647445', '14397200', '15580978', '14894817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8039119358329125
- 35 USC 102 Novelty (BERT): 0.5285910747712856
- Combined Prediction Score: 0.7763798497267498
- Mean Citation Score: 341.089354
- Max Citation Score: 366.94565
- Similarity Product: 224.2153846574336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test